0000897069-14-000020.txt : 20140128
0000897069-14-000020.hdr.sgml : 20140128
20140128170322
ACCESSION NUMBER: 0000897069-14-000020
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20140128
DATE AS OF CHANGE: 20140128
EFFECTIVENESS DATE: 20140128
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aragen Bioscience, Inc.
CENTRAL INDEX KEY: 0001594773
IRS NUMBER: 810655676
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-210871
FILM NUMBER: 14553737
BUSINESS ADDRESS:
STREET 1: 380 WOODVIEW AVENUE
CITY: MORGAN HILL
STATE: CA
ZIP: 95037
BUSINESS PHONE: (408) 779-1700, #13
MAIL ADDRESS:
STREET 1: 380 WOODVIEW AVENUE
CITY: MORGAN HILL
STATE: CA
ZIP: 95037
D
1
primary_doc.xml
X0707
D
LIVE
0001594773
Aragen Bioscience, Inc.
380 WOODVIEW AVENUE
MORGAN HILL
CA
CALIFORNIA
95037
(408) 779-1700, #13
CALIFORNIA
None
None
Corporation
true
William
R.
Srigley
380 Woodview Avenue
Morgan Hill
CA
CALIFORNIA
95037
Executive Officer
Director
Christian
C.
Simonsen
380 Woodview Avenue
Morgan Hill
CA
CALIFORNIA
95037
Executive Officer
Biotechnology
Decline to Disclose
- 06b
false
2014-01-10
true
true
true
The offering is being made in connection with the acquisiton of the Company, which will close in three separate tranches.
0
3734515
2719193
1015322
Common Stock to be issued in three tranches and Series B Preferred Stock to be issued in tranche 1.
false
1
0
0
0
false
Aragen Bioscience, Inc.
William R. Srigley
William R. Srigley
President and Chief Executive Officer
2014-01-23